Linking altered microRNA expression to racial disparities in uterine serous carcinoma
Gynecologic Oncology Dec 01, 2021
Wei JJ, et al. - Uterine serous carcinoma represents a high grade as well as an aggressive type of endometrial malignancy with a characteristic histologic, molecular, and clinical presentation. A better understanding of the basis for the observed racial disparity for uterine cancer outcomes is needed.
Uterine serous carcinoma is responsible for 10% of uterine cancers, but 40% of disease death.
A 2- to 4-fold higher incidence of aggressive endometrial cancer subtypes, specifically of uterine serous carcinoma, has been noted in African American (AA) women vs non-Hispanic (NH) White women, which could partly explain the worse survival results for uterine cancer in AA females.
Known risk factors for poorer cancer outcomes include clinical factors (e.g., obesity, diabetes, hypertension, and age at diagnosis) and socioeconomic conditions.
Other likely contributors to the survival disadvantage among AA women include tumor biology, molecular alterations, and other epigenetic features.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries